Description
A selective PKD inhibitor (IC50s = 28.3, 58.7, and 53.2 nM for PKD1, 2, and 3, respectively); inhibits prostate cancer cell migration and invasion, as well as reduces wound healing in vitro.
Formal name: 3,4-dihydro-9-hydroxy-[1]benzothieno[2,3-f]-1,4-thiazepin-5(2H)-one
Synonyms:
Molecular weight: 251.3
CAS: 1233533-04-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|PKD & PKG||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Cancer|Cell Signaling|PKD Signaling